A Drosophila model targets Eiger/TNFα to alleviate obesity-related insulin resistance and macrophage infiltration

Author:

Mirzoyan Zhasmine1ORCID,Valenza Alice2ORCID,Zola Sheri1ORCID,Bonfanti Carola2,Arnaboldi Lorenzo3ORCID,Ferrari Nicholas1ORCID,Pollard John2ORCID,Lupi Valeria2ORCID,Cassinelli Matteo2ORCID,Frattaroli Matteo2ORCID,Sahin Mehtap14ORCID,Pasini Maria Enrica2ORCID,Bellosta Paola15ORCID

Affiliation:

1. University of Trento 1 Department of Computational, Cellular and Integrative Biology (CIBIO) , , 38123 Trento , Italy

2. University of Milan 2 Department of Biosciences , , 20133 Milan , Italy

3. University of Milan 4 Department of Pharmacology , , 20133 Milan , Italy

4. University of Ankara 3 Department of Biology , , 06110 Ankara , Turkey

5. NYU Langone Medical Center 5 Department of Medicine , , 10016 New York , USA

Abstract

ABSTRACT Obesity is associated with various metabolic disorders, such as insulin resistance and adipose tissue inflammation (ATM), characterized by macrophage infiltration into adipose cells. This study presents a new Drosophila model to investigate the mechanisms underlying these obesity-related pathologies. We employed genetic manipulation to reduce ecdysone levels to prolong the larval stage. These animals are hyperphagic and exhibit features resembling obesity in mammals, including increased lipid storage, adipocyte hypertrophy and high circulating glucose levels. Moreover, we observed significant infiltration of immune cells (hemocytes) into the fat bodies, accompanied by insulin resistance. We found that attenuation of Eiger/TNFα signaling reduced ATM and improved insulin sensitivity. Furthermore, using metformin and the antioxidants anthocyanins, we ameliorated both phenotypes. Our data highlight evolutionarily conserved mechanisms allowing the development of Drosophila models for discovering therapeutic pathways in adipose tissue immune cell infiltration and insulin resistance. Our model can also provide a platform to perform genetic screens or test the efficacy of therapeutic interventions for diseases such as obesity, type 2 diabetes and non-alcoholic fatty liver disease.

Funder

Diabetic Association of Trento

National Institute of Diabetes and Digestive and Kidney Diseases

Università degli Studi di Trento

Publisher

The Company of Biologists

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology (miscellaneous),Medicine (miscellaneous),Neuroscience (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3